Work

Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial

Year: 2011

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-011-1773-y

Authors: David A. Reardon, Patrick Y. Wen, W. K. Alfred Yung, Lori Berk, Narayana Narasimhan, Christopher D. Turner, Timothy Clackson, Victor M. Rivera, Michael A. Vogelbaum

Institutions: Center for Neuro-Oncology, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Harvard University, Dana-Farber Brigham Cancer Center, The University of Texas MD Anderson Cancer Center, ARIAD Pharmaceuticals (United States), Cleveland Clinic

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1970348650

FWCI: 0.577

Cites: 36

Cited by: 20

Related to: 10